Tímarit hjúkrunarfræðinga - 2024, Blaðsíða 53

51
Ritrýnd grein | Peer review
Tímarit hjúkrunarfræðinga | 2. tbl. 100. árg. 2024
HEIMILDASKRÁ
Ásthildur Björnsdóttir. (2017). „Hver kona er bara einstök“: Reynsla og upplifun
íslenskra kvenna af breytingaskeiðinu. [Meistararitgerð, Háskólinn á Akureyri].
https://skemman.is/handle/1946/28236
CEMCOR: Centre for Menstrual Cydle an Ovulation Reearch. (ed.). Life phase
information. Sótt af http://www.cemcor.ubs.ca/life-phase-information
Donohoe, F., O'Meara, Y., Roberts, A., Comerford, L., Kelly, C. M., Walshe, J. M., . . .
Brennan, D. J. (2022). Using menopausal hormone therapy after a cancer diagnosis
in Ireland. Irish Journal of Medical Science; doi:10.1007/s11845-02-02947-6
Donovitz, G. S. (2022). A personal prospective on testosterone therapy in women—
What we know in 2022. Journal of Personalized Medicine, 12(8); doi:10.3390/
jpm12081194
Dotlic, J., Nicevic, S., Kurtagic, I., Radovanovic, S., Rancic, B., Markovic, N., Milosevic,
B. og Gazibara, T. (2020). Hormonal therapy in menopausal transition: Implications
for improvement of health-related quality of life. Gynecological Endocrinology: The
Official Journal of the International Society of Gynecological Endocrinology, 36(4),
327-332; https://doi.org/10.1080/09513590.2019.1676409
Flores, V. A., Pal, L. og Manson, J. E. (2021). Hormone therapy in menopause: Concepts,
controversies, and approach to treatment. Endocrine Reviews, 42(6), 720-752;
doi:10.1210/endrev/bnab011
Glaser, R., York, A. E. og Dimitrakakis, C. (2011). Beneficial effects of testosterone
therapy in women measured by the validated menopause rating scale (MRS).
Maturitas, 68(4), 355-361; doi:10.1016/j.maturitas.2010.12.001,
Glaser, R. L., York, A. E. og Dimitrakakis, C. (2019). Incidence of invasive breast cancer
in women treated with testosterone implants: A prospective 10-year cohort study.
BMC Cancer, 19(1), 1271; doi:10.1186/s12885-019-6457-8
Gosset, A., Robin, G., Letombe, B., Pouillès, J Trémollieres, F. (2021). Le traitement
hormonal de la ménopause en pratique. RPC les femmes ménopausées du
CNGOF et du GEMVi. Gynécologie Obstétrique Fertilité & Sénologie, 49(5), 358-372;
doi:10.1016/j.gofs.2021.03.019
Healthy people 2030. (ed). Surveillance, Epidemiology, and End Results Program
(SEER) https://health.gov/healthypeople/objectives-and-data/data-sources
-and-methods/data-sources/surveillance-epidemiology -and-end-results-
program-seer
Helga Jónsdóttir. (2021). Viðtöl í eigindlegum og megindlegum rannsóknum. Í Sigríður
Halldórsdóttir (ritstjóri), Rannsóknir Handbók í aðferðafræði (1. útg.) (bls. 147-170).
Akureyri: Háskólinn á Akureyri.
Herdís Sveinsdóttir. (2005). Tekist á við tíðahvörf: Um líðan og afstöðu 47 til 53 ára
kvenna til tíðahvarfa og notkunar tíðahvarfahormóna. Tímarit Hjúkrunarfræðinga,
81(4), 6-17.
Hjördís Sigursteinsdóttir. (2021). Úrtök og úrtaksaðferðir í megindlegum rannsóknum.
Sigríður Halldórsdóttir (ritstjóri), Rannsóknir Handbók í aðferðafræði (1. útg.) (bls.
429-441). Akureyri: Háskólinn á Akureyri.
Islam, R. M., Bell, R. J., Green, S., Page, M. J. og Davis, S. R. (2019). Safety and efficacy
of testosterone for women: A systematic review and meta-analysis of randomised
controlled trial data. The Lancet. Diabetes & Endocrinology, 7(10), 754-766;
doi:10.1016/S2213-8587(19)30189-5
Jayasena, C. N., Alkaabi, F. M., Liebers, C. S., Handley, T., Franks, S. og Dhillo, W. S.
(2019). A systematic review of randomized controlled trials investigating the
efficacy and safety of testosterone therapy for female sexual dysfunction in
postmenopausal women. Clinical Endocrinology, 90(3), 391-414; doi:10.1111/
cen.13906
La Rosa, V. L., Ciebiera, M., Lin, L., Fan, S., Butticè, S., Sathyapalan, T., . . . Favilli,
A. (2019). Treatment of genitourinary syndrome of menopause: The potential
effects of intravaginal ultralow-concentration oestriol and intravaginal
dehydroepiandrosterone on quality of life and sexual function. Przeglad
Menopauzalny / Menopause Review, 18(2), 116-122; doi:10.5114/pm.2019.86836
Lambrinoudaki, I. o.fl., (2022). Menopause, wellbeing and health: A care pathway from
the european menopause and andropause society. Maturitas, 163, 1-14; https://doi.
org/10.1016/j.maturitas.2022.04.008
LaVasseur, C., Neukam, S., Kartika, T., Bannow, B. S., Shatzel, J. og DeLoughery, T. G.
(2022). Hormonal therapies and venous thrombosis: Considerations for prevention
and management. Research and Practice in Thrombosis and Haemostasis, 6(6),
e12763; doi:10.1002/rth2.12763
Mehta, J., Kling, J. M. og Manson, J. E. (2021). Risks, benefits, and treatment modalities
of menopausal hormone therapy: Current concepts. Frontiers in Endocrinology,
doi:10.3389/fendo.2021.564781
Minkin, M. J. (2019). Menopause: Hormones, lifestyle, and optimizing aging. Obstetrics
and Gynecology Clinics, 46(3), 501-514. doi:10.1016/j.ogc.2019.04.008
Moran, V. E., Echeverria, F., Barreto, G. E., Echeverria, J. og Mendoza, C. (2021b).
Estrogenic plants: To prevent neurodegeneration and memory loss and other
symptoms in women after menopause. Frontiers in Pharmacology, doi:10.3389/
fphar.2021.644103
Moser, S.S., Chodick, G., Bar, S. og Shalev, V. (2020). Healthcare Utilization and
Prevalence of Symptoms in Women with Menopause: A Real-World Analysis.
International Journal of Women's Health, 12 (445-454).
Rasha, N. M., Saleh, M. H., Ritchie, C.W. og Minihane, A.M. (2023). Hormone
replacement therapy is associated with improved cognition and larger brain
volumes in at-risk APOE4 women: Results from the european prevention
of Alzheimer’s disease (EPAD) cohort | Alzheimer's research & therapy.
Alzheimer's Research & Therapy, 15(10), 1-13. https://alzres.biomedcentral.com/
articles/10.1186/s13195-022-01121-5
Samarasiri, D., Rajanayake, I., Wattegedara, P., Kodituwakku,
R.,Senadheera, A. og De Silva, B. S. (2017). Women’s experiences on menopause: A
phenomenological study. OUSL Journal, 12, 43- 62. https://doi.org/10.4038/ouslj.
v12i2.7407
Sigríður Halldórsdóttir. (2021). Fyrirbærafræði sem rannsóknaraðferð. Í Sigríður
Halldórsdóttir (ritstjóri), Rannsóknir handbók í aðferðafræði (1. útg.) (bls. 255-275).
Akureyri: Háskólinn á Akureyri.
Sólrún Ólína Sigurðardóttir. (2018). Kippt úr umferð í blóma lífsins: Upplifun kvenna
af snemmkomnu breytingaskeiði. [Meistararitgerð, Háskólinn á Akureyri]. https://
skemman.is/handle/1946/31125
Steinunn Kristbjörg Zophoníasdóttir. (2020). Upplifun kvenna af breytingaskeiðinu.
Þema- og frásagnagreining. [Meistararitgerð, Háskóli Íslands]. Sótt á https://
skemman.is/handle/1946/35158
Shiozawa, A., Thurston, R.C., Cook, E., Yang, H., King, D. D. Kristy. R. M og Mancuso, S.
(2023). Assessment of women’s treatment preferences for vasomotor symptoms
due to menopause. Expert Review of Pharma Research & Outcomes Research, 23,
(10), 1117–1128. https://doi.org/10.1080/14737167.2023.2250916
Uloko, M., Rahman, F., Puri, L.I. og Rubin, R.S. (2022). The clinical management of
testosterone replacement therapy in postmenopausal women with hypoactive
sexual desire disorder: a review. International Journal of Impotence research,34 (7),
635-641. https://doi.org./10.1038/s41443-022-00613-0
Vaccaro, C. M., Capozzi, A., Ettore, G., Bernorio, R., Cagnacci, A., Gambacciani, M., . . .
Lello, S. (2021). What women think about menopause: An italian survey. Maturitas,
147, 47-52. doi:10.1016/j.maturitas.2021.03.007
Verdonk, P., Bendien, E. og Appelman, Y. (2022). Menopause and work: A narrative
literature review about menopause, work and health. Work, 72(2), 483-496. https://
doi.org/10.3233/WOR-205214
Wium-Andersen, M. K., Jørgensen, T. S. H., Halvorsen, A. H., Hartsteen, B. H.,
Jørgensen, M. B., og Osler, M. (2022). Association of hormone therapy with
depression during menopause in a cohort of Danish women. JAMA Network Open,
5(11), E2239491. https://doi.org/10.1001/jamanetworkopen.2022.3949
Yisma, E., Eshetu, N., Ly, S. og Dessalegne, B. (2017). Prevalence and severity of
menopausse symptoms among perimenopausal and postmenoaupausal women
aged 30-49 years in Gulele sub-city of Addis Ababa, Ethiopia. BMC Women‘s Health.
(17, 124). https://doi.org/10.1186/s12905-017-0484-x.